Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.
(Q40287396)
scientific article published on May 2006
scientific article published on May 2006
Language:
Current Data About
Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.